Journey Medical Corp (DERM)
$7.50+$0.14 (+1.90%) Latest session
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 200,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Jun 25, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 | $0.00 | - | |
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 | $0.00 | - | |
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 | $0.00 | - | |
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 | $0.00 | - | |
| Ramsey Alloush - Officer | Grant or award | Common Stock, $0.0001 par value | 46,863 | $0.00 | - | |
| Ramsey Alloush - Officer | Grant or award | Stock Option (Right to Buy) | 62,795 | $0.00 | - | |
 Joseph Benesch - Officer | Grant or award | Common Stock, $0.0001 par value | 28,907 | $0.00 | - | |
| Joseph Benesch - Officer | Grant or award | Stock Option (Right to Buy) | 41,860 | $0.00 | - | |
| Claude Maraoui - Officer | Grant or award | Common Stock, $0.0001 par value | 49,277 | $0.00 | - | |
| Claude Maraoui - Officer | Grant or award | Stock Option (Right to Buy) | 82,915 | $0.00 | - | |
| Claude Maraoui - Officer | Option exercise | Common Stock, $0.0001 par value | 1,250,000 | $0.07 | $81K | |
| Claude Maraoui - Officer | Tax withholding / forfeiture | Common Stock, $0.0001 par value | 10,877 | $7.47 | $81K | |
| Claude Maraoui - Officer | Option exercise | Stock Option (Right to Buy) | 1,250,000 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 | $0.00 | - | |
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - |
Journey Medical Corp (DERM) had 8 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for DERM runs to 22 Form 4 filings, the earliest from 2025-06-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of DERM were filed in the last 90 days.
No insider sales of DERM were filed in the last 90 days.
This page tracks DERM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add DERM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
